On July 21-22, 2026, President Donald Trump unveiled a phased tariff plan on imported generic drugs, targeting the reshoring of pharmaceutical manufacturing to the United States. The announcement sent shockwaves…
The global demand for Indian generic medicines continues to surge in 2026, driven by India's position as the "Pharmacy of the World" — supplying over 20% of the world's generic…
India, often called the "Pharmacy of the World," supplies over 20% of the global market for generic medicines and exports pharmaceutical products to more than 200 countries. However, for international…
India’s pharmaceutical industry supplies roughly 40 percent of the United States’ generic medicines and approximately 20 percent of global demand. Yet behind this impressive export footprint lies a structural vulnerability…